retatrutide triple hormone receptor agonist metabolic obesity for dysfunction-associated steatotic liver disease: a randomized phase 2a trial retatrutide obesity triple hormone receptor
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21

























